Effect of lentil sprouts on blood lipid in patients with Type2 Diabetes.

Effect of Lentil sprouts on lipid profile, oxidaized low-density lipoprotein cholestrol and glycemic control in overweight and obese patients with Type2 Diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201305251640N9

Enrollment

Registered

2013-07-06

Start date

2013-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Type 2. Diabetes mellitus

Interventions

Intervention 1: Patients in intervention group received 60 grams of lentil sprouts per day. People will take lentil sprouts into salad with lunch and dinner. Duration of intervention will be 8 weeks

2. at this stage, lentils are placed into a lattice

3. after 30 hours, lentil sprouts are prepared. We keep this stuff into refrigerator. Intervention 2: Patients in control group will drunk one cup of boiling water a day for 8 weeks.

Treatment - Other

Placebo

Patients in intervention group received 60 grams of lentil sprouts per day. People will take lentil sprouts into salad with lunch and dinner. Duration of intervention will be 8 weeks. Sprouts recipe

3. after 30 hours, lentil sprouts are prepared. We keep this stuff into refrigerator.

Patients in control group will drunk one cup of boiling water a day for 8 weeks.

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: type II diabetes; lack of Insulin; being in the age range 65-30 years old and BMI=40-25. Exclusion criteria: pregnancy and breast-feeding women; liver disease, renal, hypothyroidism and hyperthyroidism disease; alcohol consumption, smoking, contraceptive pills; taking glucocorticoid drugs; consumption of lentil sprouts, supplements or multivitamins containing antioxidants during the 3 months prior to study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: spectophotometri.;Triglycerid. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: spectophotometri.;Low density lipoprotein cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Frewidwald formula.;High density lipoprotein cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Immunotorbidometric.;Low density lipoprotein cholestrol-oxidize. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Elaiza.;Fastig glucose. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: oxidase.;Glycated hemoglobin(HbA1c). Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: kit.;Insulin sensivity. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Quicki formula.;Insulin resistance. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: HOMA-IR.;Hemeostasis model assessment B. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: HOMA-B formula.;Insulin. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: insulin kit.	—

Measure

Time frame

Total cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: spectophotometri.;Triglycerid. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: spectophotometri.;Low density lipoprotein cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Frewidwald formula.;High density lipoprotein cholestrol. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Immunotorbidometric.;Low density lipoprotein cholestrol-oxidize. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Elaiza.;Fastig glucose. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: oxidase.;Glycated hemoglobin(HbA1c). Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: kit.;Insulin sensivity. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Quicki formula.;Insulin resistance. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: HOMA-IR.;Hemeostasis model assessment B. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: HOMA-B formula.;Insulin. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: insulin kit.

—

Secondary

Measure	Time frame
Length. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Length Gauges.;Weight. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Seca scale.;Bio mass index. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: W(kg)/H2 (m).;Waist. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: seca tape.;Hip. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: seca tape.;Physical activity. Timepoint: before and 8 weeks after intervention. Method of measurement: Physical Activity Questionnaire.;Food intake. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: dietary record questionnaire.	—

Measure

Time frame

Length. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Length Gauges.;Weight. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: Seca scale.;Bio mass index. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: W(kg)/H2 (m).;Waist. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: seca tape.;Hip. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: seca tape.;Physical activity. Timepoint: before and 8 weeks after intervention. Method of measurement: Physical Activity Questionnaire.;Food intake. Timepoint: at baseline and after 8 weeks of intervention. Method of measurement: dietary record questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Aslani

Tabriz University of Medical Ssciences

aslani_zahra@yahoo.com+98 21 3378 6422

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026